GALAPAGOS NV - Ordinary shares, no par value (GLPG)

Historical Holders from Q2 2015 to Q3 2025

Symbol
GLPG on Nasdaq
CUSIP
36315X101
Type / Class
Equity / Ordinary shares, no par value
Shares outstanding
66.2M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
31.4M
Holdings value
$1.09B
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
92
Number of buys
48
Number of sells
-40
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GALAPAGOS NV - Ordinary shares, no par value (GLPG)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GILEAD SCIENCES, INC. 29.9% $556M 21M Gilead Sciences, Inc. Jan 7, 2025
EcoR1 Capital, LLC 13.22% +11.5% $244M $25.5M 8.71M +11.7% EcoR1 Capital, LLC Jul 24, 2025
TANG CAPITAL MANAGEMENT LLC 8.4% +11.3% $193M $22.5M 5.56M +13.2% TANG CAPITAL MANAGEMENT, LLC Oct 27, 2025

Institutional Holders of GALAPAGOS NV - Ordinary shares, no par value (GLPG)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 31.4M $1.09B -$7.96M $34.64 92
2025 Q2 31.7M $887M +$28.2M $27.99 85
2025 Q1 31.1M $780M -$4.33M $25.12 82
2024 Q4 31.1M $857M +$21.1M $27.50 81
2024 Q3 13.5M $390M -$180M $28.79 77
2024 Q2 19.9M $494M -$11.5M $24.78 82
2024 Q1 20.4M $655M +$16.4M $32.20 78
2023 Q4 19.8M $804M +$24.9M $40.65 87
2023 Q3 19.1M $658M -$21.4M $34.55 72
2023 Q2 19.7M $801M +$60.8M $40.66 75
2023 Q1 18.2M $704M +$192M $38.64 74
2022 Q4 13.2M $585M +$13M $44.38 72
2022 Q3 12.9M $551M -$13M $42.64 77
2022 Q2 12.9M $720M -$9.31M $55.80 83
2022 Q1 12.8M $796M +$134M $62.02 91
2021 Q4 10.8M $595M +$111M $55.13 82
2021 Q3 8.55M $450M +$479K $52.61 81
2021 Q2 7.51M $517M +$63M $68.89 100
2021 Q1 6.56M $506M +$132M $77.09 124
2020 Q4 4.56M $452M -$397M $98.98 106
2020 Q3 7.42M $1.05B -$44M $141.91 117
2020 Q2 7.62M $1.5B -$6.42M $197.29 137
2020 Q1 7.63M $1.49B +$21.7M $195.92 136
2019 Q4 7.53M $1.56B -$161M $206.83 131
2019 Q3 8.44M $1.29B -$17.8M $152.66 108
2019 Q2 8.6M $1.11B +$26.4M $128.92 98
2019 Q1 8.43M $993M +$41.3M $117.78 94
2018 Q4 8.13M $746M -$132M $91.74 85
2018 Q3 9.42M $1.06B +$209M $112.43 95
2018 Q2 7.57M $698M -$138M $92.18 75
2018 Q1 8.97M $894M -$95.8M $99.76 81
2017 Q4 9.94M $932M -$15M $93.76 74
2017 Q3 10.1M $1.03B -$184M $101.75 69
2017 Q2 12.1M $922M +$148M $76.52 77
2017 Q1 10.1M $868M +$7.59M $86.19 63
2016 Q4 9.99M $642M +$17.9M $64.19 50
2016 Q3 9.71M $628M -$5.08M $64.66 47
2016 Q2 9.79M $543M +$57.6M $55.47 38
2016 Q1 8.77M $367M +$15.3M $41.82 32
2015 Q4 8.24M $518M -$28.7M $62.88 43
2015 Q3 9.05M $368M +$6.56M $40.71 38
2015 Q2 8.79M $453M +$453M $51.50 40